BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 19330423)

  • 1. Is bone quality associated with collagen age?
    Leeming DJ; Henriksen K; Byrjalsen I; Qvist P; Madsen SH; Garnero P; Karsdal MA
    Osteoporos Int; 2009 Sep; 20(9):1461-70. PubMed ID: 19330423
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of bone matrix proteins on fracture and fragility in osteoporosis.
    Sroga GE; Vashishth D
    Curr Osteoporos Rep; 2012 Jun; 10(2):141-50. PubMed ID: 22535528
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of collagen in bone strength.
    Viguet-Carrin S; Garnero P; Delmas PD
    Osteoporos Int; 2006; 17(3):319-36. PubMed ID: 16341622
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biomarkers for osteoporosis management: utility in diagnosis, fracture risk prediction and therapy monitoring.
    Garnero P
    Mol Diagn Ther; 2008; 12(3):157-70. PubMed ID: 18510379
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Monitoring anti-osteoporotic therapy: bone mineral density or markers of bone turnover].
    Pedersen SB; Rand MS; Eiken PA; Jørgensen NR
    Ugeskr Laeger; 2018 Aug; 180(32):. PubMed ID: 30070630
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bone quality: what is it and how is it measured?
    Compston J
    Arq Bras Endocrinol Metabol; 2006 Aug; 50(4):579-85. PubMed ID: 17117283
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of osteoporosis medications on bone quality.
    Benhamou CL
    Joint Bone Spine; 2007 Jan; 74(1):39-47. PubMed ID: 17196423
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The mineralization of bone tissue: a forgotten dimension in osteoporosis research.
    Boivin G; Meunier PJ
    Osteoporos Int; 2003; 14 Suppl 3():S19-24. PubMed ID: 12730799
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Role of Collagen Organization on the Properties of Bone.
    Garnero P
    Calcif Tissue Int; 2015 Sep; 97(3):229-40. PubMed ID: 25894071
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effects of antiresorptive therapy on the structural and material properties of bone strength].
    Kishimoto H
    Clin Calcium; 2016 Jan; 26(1):107-15. PubMed ID: 26728537
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Contribution of bone mineral density and bone turnover markers to the estimation of risk of osteoporotic fracture in postmenopausal women.
    Garnero P; Delmas PD
    J Musculoskelet Neuronal Interact; 2004 Mar; 4(1):50-63. PubMed ID: 15615078
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The roles of bone mineral density, bone turnover, and other properties in reducing fracture risk during antiresorptive therapy.
    Epstein S
    Mayo Clin Proc; 2005 Mar; 80(3):379-88. PubMed ID: 15757020
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bone quality: the determinants of bone strength and fragility.
    Fonseca H; Moreira-Gonçalves D; Coriolano HJ; Duarte JA
    Sports Med; 2014 Jan; 44(1):37-53. PubMed ID: 24092631
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of ibandronate on bone quality: preclinical studies.
    Bauss F; Dempster DW
    Bone; 2007 Feb; 40(2):265-73. PubMed ID: 16996333
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Important determinants of bone strength: beyond bone mineral density.
    Friedman AW
    J Clin Rheumatol; 2006 Apr; 12(2):70-7. PubMed ID: 16601540
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Decreased bone mineral density and periodontal management.
    Reddy MS; Morgan SL
    Periodontol 2000; 2013 Feb; 61(1):195-218. PubMed ID: 23240950
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [New pathophysological relevant metabolic pathways in osteoporosis. Future innovative therapies?].
    Neumann E
    Z Rheumatol; 2006 Sep; 65(5):400, 402-6. PubMed ID: 16924451
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Type I collagen racemization and isomerization and the risk of fracture in postmenopausal women: the OFELY prospective study.
    Garnero P; Cloos P; Sornay-Rendu E; Qvist P; Delmas PD
    J Bone Miner Res; 2002 May; 17(5):826-33. PubMed ID: 12009013
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bone quality and osteoporosis therapy.
    Martin RM; Correa PH
    Arq Bras Endocrinol Metabol; 2010 Mar; 54(2):186-99. PubMed ID: 20485908
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of genetic factors in the pathogenesis of osteoporosis.
    Stewart TL; Ralston SH
    J Endocrinol; 2000 Aug; 166(2):235-45. PubMed ID: 10927613
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.